A year from now, if they get it commercialise for paediatric, it will easily be a $1B+ MC.
Then add the adults and sleep apnea and other products with partnerships from Lockheed Martin, etc.......$5B+, it's a huge health industry their product is entering and there are no known competitors with it's patents of the machine self learning algorithm IP which (if all goes well) have been approved by the FDA!!!
Ann: Positive Results for Australian Prospective Paediatric Study, page-256
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)